Drug reference
pimobendan
Calcium sensitizer, PDE inhibitor · Positive inotropic agent, Vasodilator, Agent for acute heart failure
Calcium sensitizer, PDE inhibitorPositive inotropic agent, Vasodilator, Agent for acute heart failure
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
acute heart failure (approved in Japan)
Contraindications
- systolic pressure less than 85 mm Hg
Side effects
Serious
- increased rates of arrhythmia and death (likely related to PDE3 inhibitor activity)
Related guidelines
Ask House about pimobendan
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10